January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Shinkei Therapeutics
SHINKEI is a CNS disorders focused pharmaceutical company developing novel (NCE) candidates and re-purposing existing pharmaceutical products for new CNS indications with unmet need. Our first product is in Phase 2 trials.